EMJ Respiratory 7 [Supplement 1] . 2020

February 2020 | View in Fullscreen

In this issue

Latest articles

Flagship Journal

12 Mins

12th

December

Clinical Applications of Hyperpolarised Xenon-129 MRI

The editor’s pick for this issue is a review article discussing the promise of hyperpolarised xenon MRI, a non-invasive imaging technique… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Flagship Journal

10 Mins

12th

December

IL-5 in Type 2 Inflammatory Diseases

Type 2 inflammation is involved in severe asthma (SA), chronic rhinosinusitis with nasal polyps (CRSwNP), and eosinophilic granulomatosis… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Microbiology & Infectious Diseases

31st

October

Tackling Infectious Diseases

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain. Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

6 Mins

22nd

October

Precision Strikes: Personalising Stage IIIA Lung Cancer Treatment with Targeted and Immune Therapies

The treatment landscape for potentially surgically resectable Stage IIIA non-small cell lung cancer (NSCLC), particularly for… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.